Ogmundsdóttir H M, Jóhannesson G M, Sveinsdóttir S, Einarsdóttir S, Hegeman A, Jensson O, Ogsmundsdóttir H M
Molecular and Cell Biology Research Laboratory, Icelandic Cancer Society, Reykjavik.
Scand J Immunol. 1994 Aug;40(2):195-200. doi: 10.1111/j.1365-3083.1994.tb03450.x.
An Icelandic family with two cases of benign monoclonal gammopathy and one case each of Waldenström's macroglobulinaemia, histiocytic lymphoma and multiple myeloma was first described in 1978. Nine family members had then shown raised values for se-IgM. Of these one has since died and another was not available for testing. In four of the remaining seven se-IgM had returned to normal; the three subjects who still showed raised se-IgM included the case of multiple myeloma diagnosed in 1985. Baseline production of IgM, IgG and Ig in vitro was normal in the 35 family members studied compared with 13 healthy control subjects, but the mean production of all immunoglobulin classes in response to minimal stimulation with PWM (1 microgram/ml) was significantly increased (P < 0.05). Ten family members showed markedly increased production of all three immunoglobulin classes (> 3 x SD above mean for controls). Raised production of IgM never occurred alone, indicating intact class switching. One family member showed extremely high values: IgA: 5.15 micrograms/ml, IgG: 16.3 micrograms/ml, IgM: 24.8 micrograms/ml (means for controls: 0.066, 0.123, 0.185 respectively). These 10 family members were of both sexes, ranged in age from 16 to 84 years and were clustered mainly in three distinct groups within the pedigree suggesting heredity. Proliferative responses to PWM were not significantly increased. Serum levels of interleukin-4 were tested in the patient with multiple myeloma and the family member with highest Ig production and found to be normal. We found no evidence for depressed NK function. Thus, in this family with a tendency for macroglobulinaemia and B cell derived malignancies B cell hyperreactivity was detectable by in vitro testing in several asymptomatic family members, of both sexes and all ages. No evidence was obtained for defects in regulatory mechanisms.
1978年首次报道了一个冰岛家庭,其中有两例良性单克隆丙种球蛋白病,以及各一例瓦尔登斯特伦巨球蛋白血症、组织细胞淋巴瘤和多发性骨髓瘤。当时有9名家庭成员的血清IgM值升高。其中1人已经去世,另1人无法进行检测。其余7人中,有4人的血清IgM已恢复正常;仍显示血清IgM升高的3名受试者包括1985年诊断出的多发性骨髓瘤病例。与13名健康对照受试者相比,在研究的35名家庭成员中,IgM、IgG和Ig的体外基础产生正常,但用PWM(1微克/毫升)进行最小刺激后,所有免疫球蛋白类别的平均产生量显著增加(P<0.05)。10名家庭成员显示所有三种免疫球蛋白类别的产生量均显著增加(比对照组平均值高出>3倍标准差)。IgM产生量升高从未单独出现,表明类别转换正常。一名家庭成员的值极高:IgA:5.15微克/毫升,IgG:16.3微克/毫升,IgM:24.8微克/毫升(对照组平均值分别为0.066、0.123、0.185)。这10名家庭成员包括男女,年龄在16至84岁之间,主要集中在谱系中的三个不同组中,提示存在遗传因素。对PWM的增殖反应没有显著增加。对多发性骨髓瘤患者和Ig产生量最高的家庭成员检测了白细胞介素-4的血清水平,发现正常。我们没有发现自然杀伤细胞功能降低的证据。因此,在这个有巨球蛋白血症倾向和B细胞源性恶性肿瘤的家庭中,通过体外检测在几名不同性别和年龄的无症状家庭成员中可检测到B细胞反应性增强。没有获得调节机制缺陷的证据。